We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
7 hedge funds and large institutions have $102K invested in Decoy Therapeutics in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
30% less funds holding
Funds holding: 10 → 7 (-3)
40% less capital invested
Capital invested by funds: $170K → $102K (-$67.9K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$1.72K |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$15.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$8.45K |
| 4 |
AC
Armistice Capital
New York
|
-$2.58K |